Protected derivatives of the enone of spectinomycin
    1.
    发明授权
    Protected derivatives of the enone of spectinomycin 失效
    受保护的壮观霉素的衍生物

    公开(公告)号:US5220034A

    公开(公告)日:1993-06-15

    申请号:US847496

    申请日:1992-03-13

    申请人: Paul M. Herrinton

    发明人: Paul M. Herrinton

    IPC分类号: C07D493/04 C07D497/04

    CPC分类号: C07D493/04 C07D497/04

    摘要: Process for alkylating protected spectinomycin enone derivatives in the gamma position in order to produce intermediates useful in the synthesis of 6'alkylspectinomycins. The intermediate have the formula ##STR1## which comprises reacting a compound having the formula ##STR2## with a strong base and an alkenyl halide, wherein R.sub.1 is selected from the group consisting of alkoxycarbonyl, halogenated alkoxycarbonyl, aralkoxycarbonyl, and arylsulfone; R.sub.2 is selected from the group consisting of hydrogen, trimethylsilyl (TMS), tetrahydropyran (THP), and triethylsilyl (TES); A is selected from the group consisting of oxygen and sulfur; M is selected from the group consisting of lithium and potassium; and n is an integer from 1 to 3.

    摘要翻译: 用于在γ位置烷基化保护的壮观霉素烯酮衍生物以产生可用于合成6'-烷基保护霉素的中间体的方法。 中间体具有式III的化合物,其包括使具有式V的化合物与强碱和烯基卤反应,其中R 1选自烷氧基羰基,卤代烷氧基羰基,芳烷氧基羰基和芳基砜; R2选自氢,三甲基甲硅烷基(TMS),四氢吡喃(THP)和三乙基甲硅烷基(TES); A选自氧和硫; M选自锂和钾; n为1〜3的整数。

    Oxidative preparation of 3,5-secoandrost-5-one-3,17 .beta.-dioic acid
    7.
    发明授权
    Oxidative preparation of 3,5-secoandrost-5-one-3,17 .beta.-dioic acid 失效
    3,5-二雄甾-5-酮-3,17β-二酸的氧化制备

    公开(公告)号:US5405978A

    公开(公告)日:1995-04-11

    申请号:US158174

    申请日:1993-11-24

    申请人: Paul M. Herrinton

    发明人: Paul M. Herrinton

    摘要: The present invention is an oxidative process for the conversion of 21-unsaturated progesterones (I) ##STR1## to the corresponding 3,5-secoandrost-5-one-3,17.beta.-dioic acids (II) ##STR2## by use of either ozone or an oxidizing agent, which are useful intermediates in the production of .DELTA..sup.5 -4-aza-17-carbonyl steroids (III) which are useful in production of 5.alpha.-4-aza amide (IV) pharmaceuticals. Also disclosed are the novel 21-unsaturated progesterones (I-C) and 3,5-secoandrost-5-one-3,17.beta.-dioic acids (II-C).

    摘要翻译: 本发明是通过使用臭氧或氧化剂转化21-不饱和孕酮(I)罗哌酮-5-一-3,17β-二酸(II)(II)的氧化方法, 它们是生产可用于制备5α-4-氮杂酰胺(IV)药物的DELTA 5-4-氮杂-17-羰基类固醇(III)的有用的中间体。 还公开了新型的21-不饱和孕酮(I-C)和3,5-二雄甾-5-酮-3,17β-二酸(II-C)。